Learning Objectives

At the conclusion of this session, the participant should be able to:

• Demonstrate improved decision-making based on evidence and best practice guidelines that are standardized across the system.
• Discuss the role for multidisciplinary approaches to cranial base and pituitary pathology including surgery, radiation, and chemotherapy.
• Identify available clinical trials for patients as well as identify gaps in access for disease specific clinical trials.
• Foster cross-pollination of innovative and cutting-edge management practices among the various disciplines involved in the care of cranial base pathology

Speaker: Andrew Conger, MD, Staff Attending, Geisinger